View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
June 11, 2019updated 12 Jun 2019 6:16pm

CRF Bracket launches as Signant Health to focus on drug development

CRF Bracket, which was formed as a merged entity of CRF Health and Bracket, was launched as Signant Health.

CRF Bracket, which was formed as a merged entity of CRF Health and Bracket, was launched as Signant Health.

Combining eCOA, patient Engagement, eConsent, clinical supplies and endpoint quality into the industry’s patient-centric suite, Signant claims to simplify the process of global drug development.

The new brand is focused on patient experience, deep therapeutic area expertise, and global operational scale.

It enables sponsors and contract research organisations (CROs) to extend the reach of drug development and expand patient opportunities in clinical trials, besides improving data quality.

Signant Health chief executive officer Mike Nolte said: “The best technology in clinical research succeeds in the background.

“We work to be expert, with proven solutions and scientific support that simplify research for patients, sponsors and CROs. I’m humbled to be a part of our customers’ important work, proud of the Signant Health team and excited to continue to innovate along every step of the patient journey.”

Signant Health combines a suite of technologies with expert developers, project managers, data scientists and clinicians dedicated to help customers by introducing life-changing therapeutics.

Nolte added: “The new Signant brand reflects our desire to help separate signal from noise at the intersection of science and technology and to never forget that our customers’ significant work matters locally and globally.

“In 2018, CRF Health and Bracket brought together industry-leading technology and analytics solutions, renowned executive and scientific leaders, and 20 years of experience delivering exemplary service to life science companies worldwide. The birth of Signant Health marks the next phase in our journey and unlocks extraordinary opportunities to improve the patient’s journey as well.”


Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Clinical Trials Arena